Patents by Inventor Jose David Herazo-Maya

Jose David Herazo-Maya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR ASSESSING IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20220235417
    Abstract: Disclosed are methods and kits for evaluating predicting whether an individual IPF has slowly or rapidly progressive IPF.
    Type: Application
    Filed: March 29, 2021
    Publication date: July 28, 2022
    Applicants: The University of Chicago, The Board of Trustees of the University of Illinois, University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: Imre Noth, Yong Huang, Jose David Herazo-Maya, Naftali Kaminski, Kevin Gibson, Joe G.N. Garcia
  • Biomarkers for assessing idiopathic pulmonary fibrosis
    Patent number: 10961582
    Abstract: Disclosed are methods and kits for evaluating predicting whether an individual IPF has slowly or rapidly progressive IPF.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: March 30, 2021
    Assignees: The University of Chicago, The Board of Trustees of the University of Illinois, University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Imre Noth, Yong Huang, Jose David Herazo-Maya, Naftali Kaminski, Kevin Gibson, Joe G. N. Garcia
  • BIOMARKERS FOR ASSESSING IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20180320234
    Abstract: Disclosed are methods and kits for evaluating predicting whether an individual IPF has slowly or rapidly progressive IPF.
    Type: Application
    Filed: July 10, 2018
    Publication date: November 8, 2018
    Inventors: Imre Noth, Yong Huang, Jose David Herazo-Maya, Naftali Kaminski, Kevin Gibson, Joe G.N. Garcia
  • Biomarkers for assessing idiopathic pulmonary fibrosis
    Patent number: 10036069
    Abstract: Disclosed are methods are kits for evaluating predicting whether an individual IPF has slowly or rapidly progressive IPF.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: July 31, 2018
    Assignees: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, THE UNIVERSITY OF CHICAGO, THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: Imre Noth, Yong Huang, Jose David Herazo-Maya, Naftali Kaminski, Kevin Gibson, Joe G. N. Garcia
  • Marker Panels For Idiopathic Pulmonary Fibrosis Diagnosis And Evaluation
    Publication number: 20140335547
    Abstract: The present invention relates to the discovery that of a panel of serum or plasma markers may be used to diagnose Idiopathic Pulmonary Fibrosis (“IPF”) and distinguish this condition from other lung ailments. It further relates to the identification of markers associated with IPF disease progression.
    Type: Application
    Filed: May 14, 2014
    Publication date: November 13, 2014
    Applicants: Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas, United States Of America, Secretary, Dept. Of Health And Human Services, The University Of Chicago, University Of Pittsburgh - Of The Commonwealth System Of Higher Education
    Inventors: Naftali Kaminski, Kevin F. Gibson, Bernadette R. Gochuico, Thomas J. Richards, Ivan Rosas, Kazuhisa Konishi, Moises Selman, Jose David Herazo-Maya, Imre Noth
  • BIOMARKERS FOR ASSESSING IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20140323343
    Abstract: Disclosed are methods are kits for evaluating predicting whether an individual IPF has slowly or rapidly progressive IPF.
    Type: Application
    Filed: November 16, 2012
    Publication date: October 30, 2014
    Applicant: University of Chicago
    Inventors: Imre Noth, Yong Huang, Jose David Herazo-Maya, Naftali Kaminski, Kevin Gibson, Joe G.N. Garcia
  • Marker panels for idiopathic pulmonary fibrosis diagnosis and evaluation
    Patent number: 8846341
    Abstract: The present invention relates to the discovery that of a panel of serum or plasma markers may be used to diagnose Idiopathic Pulmonary Fibrosis (“IPF”) and distinguish this condition from other lung ailments. It further relates to the identification of markers associated with IPF disease progression.
    Type: Grant
    Filed: March 3, 2011
    Date of Patent: September 30, 2014
    Assignees: University of Pittsburgh—of the Commonwealth System of Higher Education, The University of Chicago, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas—D.F.
    Inventors: Naftali Kaminski, Kevin F. Gibson, Bernadette R. Gochuico, Thomas J. Richards, Ivan Rosas, Kazuhisa Konishi, Moises Selman, Jose David Herazo-Maya, Imre Noth